Investing.com — Jefferies in a note dated Monday upgraded Inficon Holding AG (SIX:IFCN) to a “buy” rating from
Investing.com – The Federal Reserve’s interest rate cutting cycle is over after last week’s blockbuster jobs report, analysts at Bank of America have
HONG KONG (Reuters) – Sunac China has now won the support of holders of nine of its ten onshore bonds to implement
Investing.com — The weakness seen in the S&P 500 during January 2025 is not unusual and mirrors similar patterns seen in 2024,
By Gabriel Araujo SAO PAULO (Reuters) – Private equity-backed reforestation startup re.green has signed a partnership with Agro Penido to restore 600 hectares
STOCKHOLM (Reuters) – Sweden’s SBB said on Monday that its creditor U.S. hedge fund Fir Tree Partners would end its legal proceedings
Investing.com — Shares of Entain plc (LON:ENT) climbed over 4% on Monday after the global sports betting and gaming company reaffirmed its
(Reuters) – U.S. President-elect Donald Trump last week reiterated his interest in taking control of Greenland, a semi-autonomous territory of Denmark, which
By Andrea Shalal WASHINGTON (Reuters) – U.S. President Joe Biden’s administration has concluded that China uses unfair policies and practices to dominate the
BEIJING (Reuters) – The value of China’s imports and exports with Russia reached 1.74 trillion yuan ($237 billion) in 2024, a record
FRANKFURT (Reuters) -The European Central Bank can ease policy further this year but must find a middle ground that neither induces a
Investing.com– Barclays (LON:BARC) analysts project Japan’s economy will see a resurgence in 2025, driven by domestic demand and robust wage
By Joey Roulette CAPE CANAVERAL, Florida (Reuters) – Jeff Bezos’ Blue Origin prepared for the inaugural launch of its New Glenn rocket from
By Wayne Cole SYDNEY (Reuters) – Global stocks slid broadly on Monday while the dollar hit more than two-year peaks in the wake
BERLIN (Reuters) – Commerzbank (ETR:CBKG)’s supervisory board chairman Jens Weidmann said there is little chance for an amicable merger with UniCredit after
(Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which
